{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T23:03:57Z","timestamp":1771628637559,"version":"3.50.1"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2014,6,4]],"date-time":"2014-06-04T00:00:00Z","timestamp":1401840000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0099102","type":"journal-article","created":{"date-parts":[[2014,6,4]],"date-time":"2014-06-04T20:36:31Z","timestamp":1401914191000},"page":"e99102","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":73,"title":["Allopurinol Therapy in Gout Patients Does Not Associate with Beneficial Cardiovascular Outcomes: A Population-Based Matched-Cohort Study"],"prefix":"10.1371","volume":"9","author":[{"given":"Victor C.","family":"Kok","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorng-Tzong","family":"Horng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan-Shan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Fang","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzu-Hao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,6,4]]},"reference":[{"key":"ref1","first-page":"352","article-title":"Gout: a clinical syndrome illustrated and discussed","volume":"68","author":"KJ Bhansing","year":"2010","journal-title":"Neth J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1002\/art.30520","article-title":"Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008","volume":"63","author":"Y Zhu","year":"2011","journal-title":"Arthritis Rheum"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"R66","DOI":"10.1186\/ar3322","article-title":"Hyperuricemia and the risk for subclinical coronary atherosclerosis\u2014data from a prospective observational cohort study","volume":"13","author":"E Krishnan","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/ndt\/gfq635","article-title":"Microvascular disease and its role in the brain and cardiovascular system: a potential role for uric acid as a cardiorenal toxin","volume":"26","author":"M Kanbay","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jjcc.2012.01.013","article-title":"Relationships among hyperuricemia, endothelial dysfunction and cardiovascular disease: molecular mechanisms and clinical implications","volume":"59","author":"P Puddu","year":"2012","journal-title":"J Cardiol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra0800885","article-title":"Uric acid and cardiovascular risk","volume":"359","author":"DI Feig","year":"2008","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1016\/j.diabres.2011.05.012","article-title":"Uric acid and mortality from all-causes and cardiovascular disease among adults with and without diagnosed diabetes: findings from the National Health and Nutrition Examination Survey III Linked Mortality Study","volume":"93","author":"ES Ford","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/1471-2261-12-108","article-title":"Gout and subsequent increased risk of cardiovascular mortality in non-diabetics aged 50 and above: a population-based cohort study in Taiwan","volume":"12","author":"VC Kok","year":"2012","journal-title":"BMC Cardiovasc Disord"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.cjca.2012.04.005","article-title":"Effects of allopurinol on coronary microvascular and left ventricular function in patients with idiopathic dilated cardiomyopathy","volume":"28","author":"D Erdogan","year":"2012","journal-title":"Can J Cardiol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1161\/CIRCULATIONAHA.106.651117","article-title":"High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid","volume":"114","author":"J George","year":"2006","journal-title":"Circulation"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1161\/STROKEAHA.108.519793","article-title":"Allopurinol use yields potentially beneficial effects on inflammatory indices in those with recent ischemic stroke: a randomized, double-blind, placebo-controlled trial","volume":"39","author":"SW Muir","year":"2008","journal-title":"Stroke"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.ajkd.2005.10.006","article-title":"Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level","volume":"47","author":"YP Siu","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"ref13","first-page":"829","article-title":"Allopurinol a new anti-ischemic role for an old drug","volume":"58","author":"PH Stone","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s00392-007-0636-3","article-title":"Allopurinol improves endothelial function and reduces oxidant-inflammatory enzyme of myeloperoxidase in metabolic syndrome","volume":"97","author":"O Yiginer","year":"2008","journal-title":"Clin Res Cardiol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.jacc.2012.09.066","article-title":"High-dose allopurinol reduces left ventricular mass in patients with ischemic heart disease","volume":"61","author":"S Rekhraj","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.2215\/CJN.01580210","article-title":"Effect of allopurinol in chronic kidney disease progression and cardiovascular risk","volume":"5","author":"M Goicoechea","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1365-2125.2010.03887.x","article-title":"Impact of allopurinol use on urate concentration and cardiovascular outcome","volume":"71","author":"L Wei","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.cardfail.2012.06.528","article-title":"Changes in uric acid levels and allopurinol use in chronic heart failure: association with improved survival","volume":"18","author":"I Gotsman","year":"2012","journal-title":"J Card Fail"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1001\/archinternmed.2010.198","article-title":"Gout, allopurinol use, and heart failure outcomes","volume":"170","author":"G Thanassoulis","year":"2010","journal-title":"Arch Intern Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1001\/2012.jama.11975","article-title":"Association between nucleoside analogues and risk of hepatitis B virus-related hepatocellular carcinoma recurrence following liver resection","volume":"308","author":"CY Wu","year":"2012","journal-title":"JAMA"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"E804","DOI":"10.1503\/cmaj.120518","article-title":"Risk of cancer among patients with herpes zoster infection: a population-based study","volume":"184","author":"YP Wang","year":"2012","journal-title":"CMAJ"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e50729","DOI":"10.1371\/journal.pone.0050729","article-title":"Diabetic patients with severe sepsis admitted to intensive care unit do not fare worse than non-diabetic patients: a nationwide population-based cohort study","volume":"7","author":"CW Chang","year":"2012","journal-title":"PLoS One"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/rheumatology\/kep364","article-title":"Gout: an independent risk factor for all-cause and cardiovascular mortality","volume":"49","author":"CF Kuo","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jcrc.2004.09.007","article-title":"A systematic review of the Charlson comorbidity index using Canadian administrative databases: a perspective on risk adjustment in critical care research","volume":"20","author":"DM Needham","year":"2005","journal-title":"J Crit Care"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/ije\/29.5.891","article-title":"Use of comorbidity scores for control of confounding in studies using administrative databases","volume":"29","author":"S Schneeweiss","year":"2000","journal-title":"Int J Epidemiol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1136\/heart.87.3.229","article-title":"Effect of allopurinol on mortality and hospitalisations in chronic heart failure: a retrospective cohort study","volume":"87","author":"AD Struthers","year":"2002","journal-title":"Heart"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.jacc.2010.12.052","article-title":"Mechanistic insights into the therapeutic use of high-dose allopurinol in angina pectoris","volume":"58","author":"NS Rajendra","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/S0140-6736(10)60391-1","article-title":"Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial","volume":"375","author":"A Noman","year":"2010","journal-title":"Lancet"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0099102","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T01:26:36Z","timestamp":1588987596000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0099102"}},"subtitle":[],"editor":[{"given":"Guoying","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,6,4]]},"references-count":28,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,6,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0099102","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,4]]}}}